BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 31256694)

  • 21. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 22. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges.
    Hamed KA; Tillotson G
    Expert Rev Respir Med; 2023; 17(11):973-988. PubMed ID: 37962332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region.
    Wani SR; Wattal C; Raveendran R
    Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.
    Koh WJ; Kwon OJ; Lee KS
    J Korean Med Sci; 2005 Dec; 20(6):913-25. PubMed ID: 16361797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
    Koh WJ; Stout JE; Yew WW
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline].
    Wagner D; Lange C
    Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Ying C; Zhang L; Jin X; Zhu D; Wu W
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of efficacies of different treatments for nontuberculous mycobacterial pulmonary disease in Anhui Province, China.
    Zha Z; Gao L; Wang D; Xu D; Liu Y; Liu Y; Liu S; Li J; Lin W
    J Infect Dev Ctries; 2024 May; 18(5):751-760. PubMed ID: 38865399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nontuberculous Mycobacteria-Overview.
    Koh WJ
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28128073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of nontuberculous mycobacterial pulmonary disease.
    Adelman MH; Addrizzo-Harris DJ
    Curr Opin Pulm Med; 2018 May; 24(3):212-219. PubMed ID: 29470253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia.
    Eliseev P; Hinderaker SG; Heldal E; Tarasova I; Grjibovski A; Mariandyshev A
    Infect Genet Evol; 2019 Sep; 73():358-361. PubMed ID: 31163274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines.
    Ku JH; Henkle E; Aksamit TR; Barker A; Brunton AE; Winthrop KL;
    Clin Infect Dis; 2023 Jan; 76(2):338-341. PubMed ID: 36134755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.